未找到相关数据
TAMRAD: A GINECO Randomized Phase II Trial of Everolimus in Combination with Tamoxifen Versus Tamoxifen Alone in Patients (pts) with Hormone-Receptor Positive, HER2 Negative Metastatic Breast Cancer (MBC) with Prior Exposure to Aromatase Inhibitors (AI).
被引：10
作者：
Bachelot, T.
Bourgier, C.
Cropet, C.
Guastalla, J-P
Ferrero, J-M
Leger-Falandry, C.
Soulie, P.
Eymard, J-C
Debled, M.
Spaeth, D.
Legouffe, E.
Delozier, T.
El Kouri, C.
Chidiac, J.
机构：
[1] Ctr Leon Berard, F-69373 Lyon, France
[2] Inst Gustave Roussy, Villejuif, France
[3] Ctr Antoine Lacassagne, F-06054 Nice, France
[4] Ctr Hosp Lyon Sud, F-69310 Pierre Benite, France
[5] Ctr Paul Papin, Angers, France
[6] Inst Jean Godinot, Reims, France
[7] Inst Bergonie, Bordeaux, France
[8] Ctr Oncol Gentilly, Nancy, France
[9] Clin Valdegour, Nimes, France
[10] Ctr Francois Baclesse, F-14021 Caen, France
[11] Ctr Catherine Sienne, Nantes, France
[12] Hop Hotel Dieu, F-75181 Paris, France
来源：
关键词：
D O I：
10.1158/0008-5472.SABCS10-S1-6
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
S1-6
引用
收藏
页数：2
相关论文